Fig. 7
MSC reduces nitrite and MDA levels in the spinal cord of mice with diabetic neuropathy. Four weeks after neuropathy induction, mice were treated with MSC (1 × 106; STZ + MSC) or saline (STZ + saline) by endovenous route. Control non-diabetic group received saline instead of streptozotocin. The spinal levels of nitrite (a) and MDA (b) were measured 8 weeks after treatments. Data are expressed as means ± SEM; n = 6 mice per group. *Statistical significance compared to the remaining groups (p < 0.05). One-way ANOVA followed by Tukey’s multiple comparison test